Your search for dabigatran returned 13 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Home remove

Your search for dabigatran returned 13 results

Sort Results:

Relevant Recent
Clinical Charts

Thromboembolic Disorder Assessment: DVT/PE

Risk factors, prevention strategies, signs & symptoms, and general treatment options for deep vein thrombosis (DVT) and pulmonary embolism (PE).
Clinical Charts

Confused Drug Names

Confused Drug Names according to ISMP guidelines chart
News

GI Bleed Hospitalization Risk Linked to Oral Anticoagulant Choice, PPI Cotherapy

To compare the incidence of hospitalization for upper GI tract bleeding, researchers used US Medicare beneficiary files to identify a cohort of patients that were ≥30 years old who initiated oral anticoagulation therapy with apixaban, dabigatran, rivaroxaban, or warfarin, with or without PPI cotherapy.
Drugs in the Pipeline

FDA Accepts sNDA for New Pradaxa Indication

Boehringer Ingelheim announced that the FDA has accepted for filing the supplemental New Drug Application (sNDA) for Pradaxa (dabigatran etexilate mesylate) for the prophylaxis of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have had primary elective total hip replacement surgery.